The Function of Detoxifying Fluazinam
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fluazinam was developed by the Japanese biotechnology company Ishihara Sangyo Kaisha, Ltd. (ISK) in 1990. It belongs to contact-type fungicides which kill fungi by interfering with the metabolism of energy production within fungal cells. It is particularly effective against Alternaria species, Botrytis cinerea, Phytophthora, Plasmopara viticola, Sclerotinia sclerotiorum and Fusicladium. The liver is the main target organ of fluazinam. Long-term animal tests found that fluazinam has some potential to cause neurotoxicity and disturb embryonic development and also has reproductive toxicity. As for classification of hazardous substances, technical grade fluazinam was in Acute Toxicity Category 2 for inhalation, Category 2A for serious eye damage/eye irritation, Category 1 for skin sensitization, and Category 1 for long-term hazard to aquatic environment. Hazard statements declare that fluazinam is harmful if inhaled, causes serious eye damage, may cause an allergic skin reaction, and is very toxic to aquatic life with long lasting effects.
The purpose of this experiment was to prove that Mr. Yuan Lin, the first successfully-evolved Super Human, can utilize the Absolutely Constant Energy Source (ACES) and the new biological engineering techniques to activate fluazinam to convert its chemical concentration without any change in its molecular weight, structural formula, and conformation, at 25℃, 1.0 atm, and pH 7.0, in a confined and isolated space, and with no contact with catalysts, biologically active substances, chemical substances, and physical action forces, and by means of changes in the concentration to control the potential harm of fluazinam to the human body. From the above experiment results, we can see a significant difference (p=0.025) in the concentration between the control groups and the samples treated with the ACES by Mr. Yuan Lin. It can prove that Mr. Yuan Lin, the Super Human, can utilize the Absolutely Constant Energy Source and the new biological engineering techniques to activate to fluazinam and convert and change its chemical concentration, so as to reduce the potential harm of fluazinam to the human body. Safety Data Sheet (Jul.,17, 2019). Fluazinam Standard (W01W0106-0286 JGHEEN). FUJIFILM Wako Pure Chemical Corporation. Retrieved from https://labchem-wako.fujifilm.com/sds/W01W0106-0286JGHEEN.pdf
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|